Patriot Investment Management Group Inc. Has $546,000 Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Patriot Investment Management Group Inc. trimmed its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,063 shares of the exchange traded fund’s stock after selling 375 shares during the period. Patriot Investment Management Group Inc.’s holdings in SPDR S&P Biotech ETF were worth $546,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Avior Wealth Management LLC raised its holdings in SPDR S&P Biotech ETF by 393.6% during the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after purchasing an additional 307 shares during the last quarter. Tidemark LLC grew its holdings in SPDR S&P Biotech ETF by 101.5% during the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after acquiring an additional 199 shares during the period. Quintet Private Bank Europe S.A. acquired a new position in SPDR S&P Biotech ETF in the third quarter valued at about $40,000. ORG Wealth Partners LLC bought a new position in SPDR S&P Biotech ETF during the third quarter worth about $44,000. Finally, Howe & Rusling Inc. acquired a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at approximately $49,000.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA XBI opened at $92.98 on Friday. The stock has a market cap of $7.09 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 52-week low of $81.14 and a 52-week high of $105.47. The firm has a 50 day moving average price of $93.33 and a 200 day moving average price of $96.88.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.